ACROBiosystems Inc. is an internationally recognized manufacturer of recombinant proteins committed
Location: United States, Delaware, Newark
Phone: +1 800-810-0816
Investors 1
| Date | Name | Website |
| - | The Innova... | innovation... |
Mentions in press and media 13
| Date | Title | Description |
| 02.02.2026 | ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging | SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ -- On January 11, as the global healthcare industry gathered in San Francisco, the BIOSeedin Winter Innovation Partnering Summit successfully convened ahead of J.P. Morgan 2026. ACROBiosystems, as a ... |
| 10.10.2025 | ACROBiosystems and Partners Conclude OrganoAsia 2025 | Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization SEOUL, South Korea, Oct. 10, 2025 /PRNewswire/ -- ACROBiosystems, together with Leica Biosystems, Molecular Devices, and Leica Mic... |
| 28.08.2025 | ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU for the Development of Precision Immuno-Oncology Therapeutics | SEOUL, South Korea, Aug. 28, 2025 /PRNewswire/ -- ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced that it has entered into a strategic M... |
| 21.07.2025 | CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services | Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery SEOUL, South Korea, July 21, 2025 /PRNewswire/ -- CorestemChemon, a leading GLP-certified preclinical CRO based in S... |
| 04.12.2024 | Empowering Women Through Menopause Education: Rosy’s Bold Initiative | In a world where women’s health often takes a backseat, Rosy is steering the conversation forward. The company recently announced an expansion of its menopause education campaign, aiming to empower women and healthcare providers alike. This... |
| 02.12.2024 | ACROBiosystems' US Innovation Lab Earns ISO 17025 Accreditation to Accelerate Biomedicine Discovery and Development | NEWARK, Del., Dec. 2, 2024 /PRNewswire/ -- ACROBiosystems' US Innovation Lab has recently achieved ISO/IEC 17025 accreditation for its Surface Plasmon Resonance (SPR) analytical service, ensuring that results from this service is globally r... |
| 29.09.2024 | SeromYx Systems and ACROBiosystems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies | NEWARK, Del., Sept. 29, 2024 /PRNewswire/ -- SeromYx Systems, a cutting-edge immunology technology company, and ACROBiosystems, an innovative provider for life science solutions and tools, are excited to announce the release of their joint ... |
| 19.07.2024 | ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development | NEWARK, Del., July 19, 2024 /PRNewswire/ -- At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Resilient Supply, with the mission of acceleratin... |
| 26.06.2024 | Advancing toward a brain on a chip: addressing the need to find therapeutics that work | The webinar included representatives from ACRO Biosystems, Bristol Myers Squibb, and eNuvio The human brain. It is the most complicated part of the human body. As the control center, this organ is the source of every thought and movement. I... |
| 10.04.2024 | ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research | TOKYO, April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been launching a continuous stream of innovative organoid-related products. Displaying their advancements at key global forums including the 2024 International Organ... |
Show more